Endocytosis of agonist-activated G protein-coupled receptors (GPCRs) is required for both resensitization and recycling to the cell surface as well as lysosomal degradation. Thus, this process is crucial for regulation of receptor signaling and cellular responsiveness. Although many GPCRs internalize into clathrin-coated vesicles in a dynamin-dependent manner, some receptors, including the M 2 muscarinic acetylcholine receptor (mAChR), can also exhibit dynamin-independent internalization. We have identified five amino acids, located in the sixth and seventh transmembrane domains and the third intracellular loop, that are essential for agonist-induced M 2 mAChR internalization via a dynamin-independent mechanism in JEG-3 choriocarcinoma cells. Substitution of these residues into the M 1 mAChR, which does not internalize in these cells, is sufficient for conversion to the internalization-competent M 2 mAChR phenotype, whereas removal of these residues from the M 2 mAChR blocks internalization. Cotransfection of a dominant-negative isoform of dynamin has no effect on M 2 mAChR internalization. An internalization-incompetent M 2 mutant that lacks a subset of the necessary residues can still internalize via a G proteincoupled receptor kinase-2 and ␤-arrestin-dependent pathway. Furthermore, internalization is independent of the signal transduction pathway that is activated. These results identify a novel motif that specifies structural requirements for subtype-specific dynamin-independent internalization of a GPCR.
Members of the superfamily of G protein-coupled receptors are exquisitely regulated by processes that attenuate signaling following activation by agonists (1) . These processes can be grouped according to their time course and functional effects into three main categories: desensitization, internalization, and down-regulation. Desensitization, the most rapid of these processes, occurs within seconds to minutes of receptor activation and involves uncoupling of the activated receptor from G proteins, thereby preventing further signaling. For many GPCRs, 1 this process occurs when agonist-bound receptors are phosphorylated by the G protein-coupled receptor kinase (GRK) family (2) , which promotes the association of proteins known as ␤-arrestins (3). Receptor-␤-arrestin complexes are then targeted to clathrin pits (4, 5) , leading to their internalization or sequestration from the cell surface into an intracellular compartment. Down-regulation typically occurs following prolonged exposure to agonist (hours) and can result from a combination of receptor degradation, decreased receptor expression, and posttranscriptional mechanisms (6) . The internalization of G protein-coupled receptors plays an important role in the temporal regulation of receptor function and can be a major determinant in the regulation of signaling specificity and coupling to downstream effector molecules. Following internalization, desensitized receptors generally enter into early endosomes and can be sorted into a pathway that leads either to resensitization followed by recycling to the cell surface or to entry into lysosomes and degradation (1, 7) . For example, following activation, ␤ 2 -adrenergic receptors are phosphorylated, which in turn promotes desensitization and internalization. The internalized receptors enter into the recycling pathway where the lower pH promotes agonist dissociation and dephosphorylation by a vesicular phosphatase (8) . These resensitized receptors are then returned to the cell surface where they can again be activated. In contrast, internalization appears to attenuate resensitization of M 4 mAChRs (9) . Furthermore, internalization of some GPCRs may allow coupling to a different complement of effector molecules, thereby contributing to the temporal and spatial regulation of intracellular signaling. This was demonstrated by the finding that internalization appears to be required for the activation of mitogen-activated protein kinases by the ␤ 2 -adrenergic receptor via a poorly understood mechanism (10, 11) .
Clathrin-mediated endocytosis is dependent upon the GTPase activity of dynamin. Receptor activation leads to the association of cytosolic dynamin with coated pits, where it induces the budding of pits and the formation of clathrin-coated vesicles (12, 13) . For most GPCRs that have been examined, internalization occurs by this dynamin-dependent mechanism and can be blocked by treatments that either destabilize clathrin-coated pits or block the actions of dynamin (1, 14) . GTPase defective mutants of dynamin act as dominant-negative inhibitors of dynamin activity and block coated-vesicle formation and agonist-stimulated GPCR internalization (15, 16) . Recently, a number of GPCRs have been identified that exhibit dynamin-independent internalization. These include the AT 1A angiotensin receptor (16) , the D 2 dopamine receptor (17) , the secretin receptor (18) , and the M 2 mAChR (19, 20) . Interest-* This work was supported by National Institutes of Health Grant HL58676. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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In JEG-3 human choriocarcinoma cells, the G i -coupled M 2 mAChR undergoes agonist-induced internalization, whereas the G q -coupled M 1 mAChR does not (21) . We previously used chimeric M 1 -M 2 mAChRs to show that the region necessary for M 2 mAChR-specific internalization in JEG-3 cells is between Glu-382 and Leu-442, which includes six amino acids at the C-terminal end of the third intracellular loop (I3) and transmembrane domains 6 and 7 (TM6 and TM7) (21) . M 2 mAChR chimeras containing either TM6 or this portion of I3 from the M 1 mAChR did not exhibit agonist-induced internalization. In this study, we demonstrate that the endogenous M 2 -specific internalization pathway in JEG-3 cells is dynamin-independent and use a gain-of-function analysis to identify the specific amino acids necessary for coupling of the M 2 mAChR to this pathway. The results demonstrate that the M 2 -specific internalization pathway exhibits a novel sequence requirement for five amino acids in three topologically distinct regions of the M 2 mAChR. DNA Constructs-The M 1 and M 2 mAChR expression vectors and generation of the M 2 /M 1 (6) receptor have been described previously (21) . The M 2 /M 1 (6) is an M 2 mAChR chimera in which TM6 has been converted to the M 1 mAChR sequence. Using mutagenic primers and sequential PCR with Pfu polymerase (Stratagene), M 1 (VTIL) was created from the wild type M 1 mAChR and then used to create M 1 (VTILA) as described (21) . M 1 (A) was generated from M 1 (VTILA) by subcloning a 328-base pair XcmI/BstEII fragment containing the M416A mutation back into the wild type M 1 mAChR. Wild type dynamin-1 and dominant-negative dynamin-K44E were generously provided by Dr. R. B. Vallee (University of Massachusetts), and GRK2 and ␤-arrestin-1 were provided by Dr. R. J. Lefkowitz (Duke University). The M 2 (VTIL3AALS) receptor (22, 23) was obtained from Dr. J. Wess (National Institutes of Health, Bethesda, MD). All other constructs have been described elsewhere (24) .
EXPERIMENTAL PROCEDURES

Materials
Cell Culture and Transfection-JEG-3 and COS-7 cells (American Type Culture Collection, Manassas, VA) were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin at 37°C in a humidified 10% CO 2 environment. Unless stated otherwise, transiently transfected cells were subcultured 20 -24 h after transfection and analyzed 44 -48 h after transfection. Transfection on 24-well plates and subsequent assays of luciferase and ␤-galactosidase activity were performed essentially as described (24) . Briefly, cells seeded at 30,000/well were transfected 48 h later using the calcium phosphate precipitation method (25) with 200 -315 ng of total DNA/well. Transfection mixes included the following expression vectors in the combinations as described in the figure legends: 30 -100 ng/well of receptor cDNA, 25 ng/well of ␣168 CRE-luciferase, 40 ng/well of RSV-␤-galactosidase, and 0 -100 ng/well of G␣ i -2. The total DNA for each transfection mixture in a given experiment was kept the same by the addition of carrier DNA. The medium was changed 20 -24 h after transfection, and cells were treated with various drugs as described in the figure legends an additional 20 -24 h later.
For whole-cell internalization and down-regulation assays and for determination of phosphatidylinositol (PI) hydrolysis, JEG-3 or COS-7 cells (approximately 60 -70% confluent) were transfected according to the calcium phosphate precipitation method and treated with 100 M chloroquine for 3-4 h followed by a 3-min treatment with 15% glycerol in HEPES-buffered saline (20 mM HEPES, 0.7 mM Na 2 HPO 4 , 137 mM NaCl, 5.0 mM KCl, 5.6 mM dextrose, pH 7.05). For internalization and down-regulation assays, JEG-3 cells on 150-mm plates were transfected with 25 g of receptor DNA, whereas for determination of PI hydrolysis, COS-7 cells on 100-mm plates were transfected with 5 g receptor DNA.
Receptor Internalization Assays-Determination of mAChR internalization in transiently transfected JEG-3 cells was accomplished using the binding of the membrane-impermeable muscarinic ligand [ 3 H]NMS to intact cells using a variation of a previously published method (24) . Briefly, 20 -24 h after transfection, JEG-3 cells from one 150-mm culture dish were subcultured onto three 6-well plates and allowed to attach for an additional 24 h. The cells were treated with various concentrations of carbachol for 0 -60 min as described in the figure legends (3 wells/condition), washed three times with 3 ml of ice-cold phosphate-buffered saline (PBS: 4.3 mM Na 2 HPO 4 , 1.4 mM KH 2 PO 4 , 137 mM NaCl, 2.7 mM KCl, pH 7.4), and labeled with approximately 1 nM [
3 H]NMS in PBS for 4 -5 h at 4°C. Nonspecific binding was determined in the presence of 1 M atropine. Labeled cells were washed three times with 3 ml of ice-cold PBS, solubilized in 0.5 ml 1% Triton X-100, and combined with scintillation mixture before the determination of radioactivity by scintillation counting. Data are expressed as the percent of total receptors not accessible to the membrane-impermeable ligand.
Receptor Down-regulation Assays-Determination of mAChR downregulation in transiently transfected JEG-3 cells was accomplished using the binding of the membrane-permeable muscarinic ligand [ 3 H]QNB to intact cells similar to that described (26) . Briefly, 20 -24 h after transfection, JEG-3 cells from one 150-mm culture dish were subcultured onto three 6-well plates and allowed to attach for an additional 24 h. The cells were treated with various concentrations of carbachol for 0 -4 h, as described in the figure legends (3 wells/condition), washed 3 times with QNB assay buffer (116 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl 2 , 0.81 mM MgSO 4 , 1.0 mM NaH 2 PO 4 , 25 mM glucose, 25 mM HEPES, pH 7.4), incubated for 15 min at 37°C, and then labeled with approximately 0.6 nM [
3 H]QNB for 90 min at 37°C. Nonspecific binding was determined in the presence of 1 M atropine. Cells were placed on ice, washed with ice-cold PBS, and then filtered onto GF/C filters (Whatman). The filters were washed four times with ice-cold PBS, transferred to scintillation vials, and combined with scintillation mixture before determination of radioactivity by scintillation counting. Data are expressed as the percent of total receptors down-regulated.
cAMP Regulation Assays-Changes in cAMP levels were measured using a luciferase reporter gene under the transcriptional control of a cAMP-regulated promoter (CRE-luciferase) (24, 27, 28) . The Rous sarcoma virus ␤-galactosidase gene was included to correct for minor variations in transfection efficiency. All drug treatments occurred 44 -48 h after transfection. Cells cotransfected with the G␣ i -2 expression construct were stimulated with 0.4 M forskolin to allow the measurement of inhibitory coupling following receptor activation by the concentrations of carbachol indicated in the figure legend. To measure stimulation of cAMP production by mAChRs, cells were transfected as described, except that the amount of receptor cDNA was increased to 100 ng/well and G␣ i -2 was not included. Cells for these experiments were treated with 1 mM carbachol without forskolin. In all cases, drug treatments were for 5 h at 37°C and terminated by washing the cells with ice-cold PBS. For some experiments, cells were treated with 300 nM pertussis toxin (PTX) for 24 h before drug treatment. After drug treatments, cells were lysed and assayed for luciferase and ␤-galactosidase activities as described previously (27) . Data were normalized for transfection efficiency and corrected for the background activity seen in unstimulated cells.
Determination of PI Hydrolysis-COS-7 cells grown on 100-mm dishes were transfected with 5 g of receptor DNA. COS-7 cells were used because they have a lower endogenous PI response to carbachol treatment than JEG-3 cells.
2 Approximately 24 h after transfection, cells were subcultured onto two 6-well tissue culture dishes and allowed to attach for 4 h. One plate was incubated for an additional 16 -20 h and then subjected to whole cell binding assays using [ 3 H]NMS as described above. To the remaining plate, the growth medium was supplemented with 1 Ci/ml myo- [ 3 H]inositol, and the cells incubated for an additional 16 -20 h. The cells on this latter plate were washed 3 times with physiological saline solution (118 mM NaCl, 4.7 mM KCl, 3 mM CaCl 2 , 1.2 mM MgSO 4 , 1.2 mM KH 2 PO 4 , 10 mM glucose, 0.5 mM EDTA, 20 mM HEPES, pH 7.4) containing 10 mM LiCl and incubated for 30 min at 37°C, and then triplicate wells were stimulated without (control) or with 1 mM carbachol for 20 min at 37°C. Total inositol phosphates were isolated using ion-exchange chromatography (Bio-Rad AG 1-X8, 100 -200 mesh, formate form) as described (29) . Data are expressed as fold-induction above untreated controls after correcting for receptor expression levels.
Molecular Modeling-The three-dimensional model for the M 2 mAChR was constructed using a published model of bovine rhodopsin (30) as a template. Interactive graphics model building was performed using the PSSHOW package (31) , and the model was displayed using the SWISS-PDB viewer (32).
RESULTS
Identification of Multiple Epitopes Necessary for M 2 -specific
Internalization-There is a high degree of sequence identity between the M 1 and M 2 mAChRs in the membrane-proximal regions of the I3 loop, TM6 and TM7 (Fig. 1B) . Our previous studies demonstrated that sequences from the C-terminal region of I3 as well as from TM6 were necessary for M 2 -specific internalization in JEG-3 cells (21) . Because sequences at the membrane-cytoplasmic interface seemed likely to be responsible for these differences in internalization, we tested the role of these residues in M 2 -specific internalization. Molecular modeling suggests that the ␣-helix of TM6 extends into I3, and four of the unique M 2 mAChR residues in this region, termed the VTIL sequence (Val-385, Thr-386, Ile-389, Leu-390), are predicted to be on the same ␣-helical face on either side of the membrane-cytoplasmic interface (reviewed in Ref. 33 ; see Fig.  8 ). Substitution of the VTIL sequence for the corresponding residues in the M 1 mAChR (the M 1 (VTIL) receptor) caused a slight shift in the dose dependence and an enhancement in the time course of internalization (Fig. 2, A and B) that was still much less than that seen with the M 2 mAChR. Analysis of the first-order exponential decay curve (Fig. 2B, inset) showed that substitution of the VTIL sequence led to an approximately 20-fold increase in the initial rate of internalization in the presence of carbachol compared with an approximately 75-fold difference with the M 2 mAChR (Table I) . Consistent with our previous results using chimeric receptors (21) , conversion of this region of the M 2 mAChR to the corresponding residues of the M 1 mAChR (VTIL 3 AALS) caused a complete loss of agonist-induced internalization. 3 These data demonstrate that this region is necessary for M 2 mAChR internalization but that additional structural elements are necessary.
Because we favored the hypothesis that sequences near the membrane-cytoplasmic interface mediated subtype-specific internalization and our previous studies did not test the potential involvement of TM7, we tested if residues in TM7 apposed to the VTIL sequence in TM6 were involved. There are three differences between the M 1 and M 2 mAChRs in this region: two valine/isoleucine substitutions near the middle of TM7 and a methionine/alanine substitution nearer to the cytoplasmic end of TM7 (Met-416 in M 1 versus Ala-438 in M 2 ) (Fig. 1B) . The proximity of Ala-438 to the cytoplasmic-TM7 interface led us to test its effects on internalization by making Met-416 3 Ala substitutions in the wild type M 1 and M 1 (VTIL) receptors to create the M 1 (A) and M 1 (VTILA) receptors, respectively.
The Met-416 3 Ala mutation alone had only slight effects on the internalization of the M 1 mAChR (Fig. 2, A and B) , leading to an approximately 10-fold increase in the initial rate of internalization in the presence of carbachol (Fig. 2B , inset, and Table I ). In stark contrast, this mutation in combination with the AALS 3 VTIL substitution created a receptor whose internalization profile closely resembled that of the M 2 mAChR. Both the dose dependence and time course of internalization of the M 1 (VTILA) receptor were enhanced (Fig. 2, A and B ) compared with the M 1 (A) and M 1 (VTIL) receptors. Although the maximal extent of internalization for the M 1 (VTILA) receptor was slightly less than the M 2 mAChR (Fig. 2B) , the initial rate of internalization for the two receptors was almost identical (66-fold increase for M 1 (VTILA) versus 75-fold increase for M 2 ) (Fig. 2B , inset, and Table I ). Together, these data suggest that multiple structural elements must come together within the M 2 mAChR in order for it to become internalization-competent in JEG-3 cells. These structural elements appear to be provided by Val-385, Thr-386, Ile-389, and Leu-390 at the I3/TM6 interface in combination with Ala-438 in TM7.
Dynamin Independence of M 2 mAChR Internalization in JEG-3 Cells-Stimulation of transiently transfected JEG-3 cells with muscarinic agonist leads to the rapid internalization of M 2 but not M 1 mAChRs (21). Many GPCRs internalize via clathrin-coated vesicles (34) . Phosphorylation of activated receptors by GRKs leads to the binding of ␤-arrestins, which act as clathrin adapters. Budding of clathrin-coated pits is regulated by dynamin and can be inhibited by expression of a dominant-negative dynamin mutant (e.g. Dyn-K44E) (14) . Because the M 2 mAChR can internalize via dynamin-dependent and -independent internalization pathways depending on the nature of the molecules that are coexpressed (19, 20) , we sought to determine whether the M 2 -specific pathway in JEG-3 cells utilizes dynamin.
To mAChR internalization (Fig. 3A) , indicating that this process is dynamin-independent. In addition, internalization of the M 2 mAChR by the M 2 -specific pathway appears to be independent of GRKs and arrestins. Because the GRK phosphorylation sites in the M 2 mAChR are in the middle of I3 (35) and not necessary for internalization (36) , it is unlikely that GRK phosphorylation is involved with the M 2 -specific internalization pathway in JEG-3 cells. Substitution of TM6 from the M 1 mAChR into the M 2 mAChR (M 2 /M 1 (6)) ablates agonist-induced internalization (21) , presumably due to conversion of Ile-389 and Leu-390 to the corresponding M 1 residues. To determine if residues within the VTILA sequence were required for internalization by an alternative mechanism, JEG-3 cells were cotransfected with M 2 /M 1 (6) in the presence of GRK2 and ␤-arrestin-1. Cotransfection of GRK2 and ␤-arrestin-1 with M 2 /M 1 (6) restored internalization (Fig. 3B) to levels very similar to that seen with wild type M 2 mAChR when coexpressed with GRK2 and ␤-arrestin-1 (24), indicating that this receptor is fully competent to internalize by an alternative mechanism. In addition, these data suggest that the M 2 -specific pathway is independent of the GRK/␤-arrestin-dependent pathway. Furthermore, the M 1 mAChR was relatively insensitive to the effects of GRK2 and ␤-arrestin-1 expression, indicating that these effects are specific for the M 2 mAChR.
Down-regulation of Wild Type and Mutant mAChRs in
Transiently Transfected JEG-3 Cells-After internalization, GPCRs can either be recycled to the cell surface or directed to lysosomes and degraded. In HEK-293 (20) and JEG-3 cells, 2 recycling of the M 2 mAChR to the cell surface is very slow, and many of the receptors appear to be degraded. To determine whether the internalization-competent mutant M 1 receptors were sorting into a similar endocytic pathway, the extent of receptor down-regulation after prolonged agonist treatment was determined. All of the wild type and mutant mAChR constructs underwent a time-dependent decrease in total receptor number following exposure to carbachol. Down-regulation of the M 2 mAChR was approximately 2-fold greater than the M 1 mAChR following both 1-and 4-h agonist treatments (Fig. 4) . The extent of M 1 (VTILA) receptor down-regulation was very similar to that of the M 2 mAChR, whereas both the M 1 (A) and M 1 (VTIL) receptors were between that of the M 1 and M 2 mAChRs ( Fig. 4 ; M 1 was significantly different from both M 2 and M 1 (VTILA) at both times; M 1 (VTIL) was significantly different from M 2 at 1 h and both M 1 and M 2 at 4 h). This pattern is similar to the differences seen for agonist-induced internalization (Fig. 2B) and suggests that the M 1 (VTILA) and M 2 receptors sort into the same endocytic pathway.
Functional Analysis of Wild Type and Mutant mAChRs-The VTIL sequence has been implicated in coupling of the M 2 mAChR to the G i/o family of G proteins (22, 23) , whereas the corresponding residues in the M 3 mAChR (Ala-488, Ala-489, Leu-492, and Ser-493; AALS) have been implicated in coupling to the G q family of G proteins (37) . Like the M 3 mAChR, the G q -coupled M 1 mAChR also contains the AALS sequence in the corresponding location. Alanine 438 is located within the highly conserved NPXXY motif, which is involved in agonist binding and GPCR signaling (38, 39) . For these reasons, we tested if the differences in internalization of the wild type and mutant M 1 and M 2 mAChRs were related to differences in their G protein coupling. Because the M 1 mAChR is a prototypical G q -coupled receptor, we first examined the ability of the mutant M 1 receptors to activate phospholipase C (PLC). In cells transiently transfected with the M 1 mAChR, maximal stimulation with carbachol led to an approximately 5-fold stimulation of PLC activity, whereas in cells transfected with the M 2 mAChR, maximal stimulation of PLC activity was approximately 2-fold above unstimulated controls. Treatment of cells transfected with any of the mutant receptors (e.g. M 1 (VTIL), M 1 (VTILA), and M 1 (A)) led to maximal stimulation of PLC activity that was very similar to that seen with the wild type M 1 mAChR (Fig. 5) . These data indicate that in the M 1 mAChR, the AALS sequence is not necessary for coupling to PLC, a predominately G q -coupled response. Furthermore, they . The inset shows the data for disappearance from the cell surface fit to a first-order exponential decay curve. Cell-surface receptors were measured using the membrane-impermeable muscarinic antagonist [ 3 H]NMS as described under "Experimental Procedures." Data are expressed as the percent of receptors internalized and represent the means Ϯ S.E. of three to six independent experiments, each performed in triplicate.
TABLE I Wild type and mutant mAChR receptor internalization rate constants
First order rate constants for the disappearance of wild type and mutant receptors from the cell surface following treatment with 0.1 mM carbachol were determined from the inset in Fig. 2B suggest that each of the mutant receptors is fully functional and capable of stimulating a functional response that is essentially equivalent to the wild type M 1 mAChR. To measure coupling of the mutant receptors to G i proteins, changes in intracellular cAMP were determined using a luciferase reporter gene under the control of a cAMP-regulated promoter (CRE-luciferase). We have previously used this method to measure coupling of the M 2 and M 4 mAChRs to G i proteins (when cotransfected with G␣ i -2) as well as ectopic coupling of all mAChR subtypes to stimulation of adenylyl cyclase (AC) via G s (27, 28) . As demonstrated previously, the M 2 mAChR couples to transfected G i ␣-2, inhibiting forskolinstimulated AC activity and CRE-luciferase expression in a dose-dependent fashion (Fig. 6) . Consistent with previous work from our laboratory (27) , the M 1 mAChR did not couple to G i proteins and stimulated AC directly in a dose-dependent fashion, leading to increased CRE-luciferase expression in cells even when G␣ i -2 is overexpressed (Fig. 6 ). Under these same conditions, the M 1 (A) receptor stimulated AC to levels similar to that of the M 1 mAChR. Unexpectedly, the mutant M 1 receptors that contain the VTIL sequence (e.g. M 1 (VTIL) and M 1 (VTILA)) did not appear to regulate AC activity (Fig. 6) , which suggests that the VTIL sequence is not sufficient to confer G i coupling but might be sufficient to interfere with ectopic G s coupling. We also found that conversion of the VTIL sequence in the M 2 mAChR to the corresponding amino acids in the M 1 mAChR (e.g. M 2 (VTIL3 AALS)) resulted in a complete loss of coupling to inhibition of CRE-luciferase expression. 3 These data are consistent with the work of others (22, 23) , which demonstrated that the VTIL sequence is necessary for M 2 mAChR coupling to the G i/o protein family but differ in that the VTIL sequence does not appear to be sufficient to confer inhibitory coupling to the M 1 mAChR.
There are two obvious explanations for the apparent inability of the M 1 (VTIL) and M 1 (VTILA) receptors to regulate AC activity: 1) that these receptors can couple to neither G i nor G s proteins or 2) that these receptors can couple to both G i or G s proteins so that their effects on AC activity counteract each other. To examine these hypotheses, we first tested the mutant M 1 receptors for the ability to stimulate AC activity in cells lacking transfected G␣ i subunits. In the absence of transfected G␣ i , treatment of JEG-3 cells expressing the M 2 mAChR with carbachol in the absence of forskolin stimulates AC activity but to a lower extent than in cells expressing the M 1 mAChR (27), (Fig. 7, A and B) . In general, all of the receptors that contain the VTIL sequence (M 2 , M 1 (VTIL), and M 1 (VTILA)) were able to stimulate AC activity but to a lesser extent than receptors that contained the AALS sequence (M 1 and M 1 (A)) (Fig. 7, A  and B ). Next, we tested if any of the wild type or mutant receptors might be coupling to both stimulatory and inhibitory G proteins by treating transfected cells with PTX to inactivate G i/o proteins and then stimulating with carbachol in the absence of forskolin. Inactivation of G␣ i/o subunits with PTX led to increased stimulation of AC by carbachol in cells expressing the M 1 (VTIL) and M 1 (VTILA) receptors that was approximately 2-fold greater than that seen in cells stimulated with carbachol alone (Fig. 7B) . Stimulation of AC activity by the M 1 and M 1 (A) receptors was unaffected by PTX treatment, whereas PTX treatment alone had only minor effects on AC activity and CRE-luciferase expression. Increased stimulation of AC activity following PTX treatment is due to decreased inhibitory coupling and suggests that these receptors can couple to endogenous G i/o proteins. Together, these data indicate that the M 1 (VTIL) and M 1 (VTILA) receptors can couple to both stimulation and inhibition of AC activity and that the VTIL sequence is necessary but not sufficient for efficient coupling to G i/o . Most importantly, the similar functional properties of the internalization-incompetent M 1 (VTIL) receptor and the internalization-competent M 1 (VTILA) receptor indicate that internalization by the M 2 -specific pathway is independent of the signaling specificity of the receptor.
Molecular Model of the VTILA Motif-To better understand the role that the VTILA motif plays in G protein coupling and internalization, we generated three-dimensional models of the M 2 mAChR helical bundle (Fig. 8) based on a published model of rhodopsin (30) . In rhodopsin, a methionine (corresponding to Ile-392 in the M 2 mAChR) near the region analogous to the VTIL sequence is situated between TM6 and TM7 and tightly packed with side chains of the NPXXY motif (40) . Because Ala-438 is within the NPXXY motif, this would position the VTIL sequence very near the region that contains Ala-438 in the M 2 mAChR. Analysis of the molecular model for the region containing TM6 and TM7 of the M 2 mAChR demonstrates that the VTIL sequence is oriented toward the center of the helical bundle, and Ala-438 is oriented outward (Fig. 8) . This suggests that Ala-438 does not interact with side chains of the VTIL sequence but may interact with other molecules to facilitate endocytosis.
DISCUSSION
Stimulus-dependent internalization performs a critical role in the regulation of GPCR function. Entry of receptors into early endosomes allows them to be sorted into pathways leading either to resensitization or down-regulation (1, 7). Regulation of these intracellular sorting pathways provides an additional mechanism to modulate receptor function and can ultimately determine the signaling strength of a receptor system. For some GPCRs, internalization also allows coupling to additional second messenger pathways (10, 11) . For these receptors, desensitization followed by internalization does not block signaling entirely but instead alters the receptor-effector coupling profile and leads to the activation of a different subset of signals, thereby providing for precise temporal regulation of multiple signaling pathways by a single receptor system.
Each member of the mAChR family can undergo agonistinduced internalization if expressed in the appropriate cell type. For example, the M 1 mAChR does not rapidly internalize when expressed in JEG-3 cells (21) but readily internalizes following agonist activation when expressed in Y1 cells (41) HEK-293 cells (20, 42) . This is in contrast to the M 2 mAChR, which internalizes in each of the above cell lines following exposure to agonists. In this report, we utilized the different internalization patterns of the M 1 and M 2 mAChRs in JEG-3 cells to identify specific structural elements necessary for coupling to this M 2 -specific internalization pathway. Specifically, we demonstrated that conversion of five amino acids in the M 1 mAChR to their M 2 mAChR counterparts (Val-385, Thr-386, Ile-389, Leu-390, and Ala-438; VTILA) was sufficient for conversion to the M 2 -like internalization-competent phenotype (Fig. 2) . In addition, we provided evidence that the M 2 -specific pathway is independent of dynamin ( Fig. 3A) , which suggests that the M 2 mAChR internalizes by a mechanism other than clathrin-mediated endocytosis in JEG-3 cells.
The initial rates of internalization of the M 1 (VTILA) and M 2 receptors were nearly indistinguishable, but the M 1 (VTILA) receptor did not appear to internalize to quite the same maximal extent as the M 2 mAChR. This pattern of M 1 (VTILA) receptor internalization is very similar to the M 1 /M 2 (VT-6,7) receptor, a chimeric M 1 mAChR in which a region bounded by the C-terminal portion of the I3 loop and TM7 was exchanged for the corresponding region of the M 2 mAChR (21). Comparison of the M 1 (VTILA) and M 2 mAChR time courses of internalization suggests that there might be two components or phases to the internalization process: a fast component mediated by the VTILA motif and a slower component that is independent of the VTILA motif. These observations raise the possibility that other regions of the M 2 mAChR might also be involved in agonist-dependent dynamin-independent internalization in JEG-3 cells. What other regions of the M 2 mAChR might be involved? One possibility is the I3 loop. This region is phosphorylated in response to agonist in both JEG-3 (24) and HEK-293 (35) cells and appears to play a role in arrestin-and dynaminindependent internalization in HEK-293 cells (19) . In addition, the I3 loop appears to mediate a GRK-and ␤-arrestin-dependent mechanism of desensitization when these proteins are overexpressed in JEG-3 cells (24) . Whether regions of the I3 loop are necessary for participation in the pathway that requires the VTILA motif is not known.
Currently, very little is known about the mechanisms by which structurally similar receptors are differentially sorted. Recently, Vickery and von Zastrow (17) demonstrated that the D 1 and D 2 dopamine receptors are selectively internalized into dynamin-dependent and -independent pathways when expressed in HEK-293 cells. Following internalization, both the D 1 and D 2 receptors were rapidly recycled back to the cell surface. In a similar fashion, the M 1 and M 2 mAChRs are selectively internalized into dynamin-dependent and -independent pathways in HEK-293 cells (19, 20) . In contrast to the D 1 and D 2 receptors, the M 1 mAChR returns very rapidly to the cell surface following internalization in HEK-293 cells but the M 2 mAChR does not (20) . We have found that when expressed in JEG-3 cells, internalized M 2 mAChRs are also very slow to return to the cell surface. 2 In the current study, we show that long term (4 h) treatment with agonist leads to moderately higher levels of down-regulation for the M 2 mAChR than for the M 1 mAChR (Fig. 4) . Substitution of the VTILA residues into the M 1 mAChR led to significantly higher levels of downregulation (Fig. 4) , which suggests that the M 1 (VTILA) receptor is sorting into the same endocytic pathway as the M 2 mAChR.Giventhatrecentworkhasdemonstratedthatdynamindependent endocytosis can also lead to down-regulation of GPCRs (43) , it now seems likely that selective internalization into a particular pathway (dynamin-dependent versus -independent) does not commit receptors to a particular fate (resensitization versus down-regulation) and that intracellular sorting of internalized receptors must also be regulated.
The mechanism by which the VTILA motif mediates subtype-specific internalization of the M 2 mAChR remains to be elucidated. Because the VTIL sequence has been previously implicated in M 2 mAChR coupling to G i proteins (22) , whereas the corresponding AALS sequence was reported to be necessary for M 3 mAChR coupling to G q proteins (37), we tested if the G protein coupling patterns of the mutant M 1 receptors correlated with their internalization phenotypes. We found that replacement of the AALS sequence of the M 1 mAChR with the VTIL sequence conferred partial coupling to inhibition of AC activity (Figs. 6 and 7) but did not appear to interfere with PLC coupling (Fig. 5) . This contradicts previous studies that identified the VTIL sequence as being necessary and sufficient for coupling to G i proteins (22) . These authors examined the effects of AALS to VTIL substitutions in the M 3 mAChR, and it is possible that subtle differences in the M 1 and M 3 mAChRs are responsible for the differences in coupling specificity. Furthermore, the AALS sequence conferred only partial G q -coupling to the M 2 mAChR (37), whereas the effect of the loss of this sequence was not examined. Most importantly, our results demonstrate that the G protein coupling patterns of the wild type and mutant M 1 and M 2 mAChRs expressed in JEG-3 cells do not correlate with the internalization phenotype. Together, these observations suggest that coupling of the M 2 mAChR to the VTILA-dependent internalization machinery is independent of G protein-coupling and downstream signaling events.
To better understand how the VTILA motif might be involved in M 2 mAChR internalization, we generated a threedimensional model of the M 2 mAChR based on a published model of rhodopsin (30) . Based on our internalization data, we hypothesized that Ala-438 in TM7 might be interacting with side chains of the VTIL sequence. Examination of the model, however, shows that this is highly unlikely (Fig. 8) . The VTIL residues are found on one side of the helix on the interior of the helical bundle, whereas Ala-438 lies on the outside of TM7. Given the putative interactions among the side chains of TM6 and TM7 (see "Results"), it is likely that changes in secondary structure within this region following agonist binding occur in a coordinated fashion. Interestingly, immunological experiments demonstrate that the NPXXY motif in rhodopsin becomes exposed to the cytosol following activation (44), indicating that this region would be ideally suited to interact with activation-dependent endocytic machinery.
What the VTILA motif might be interacting with is not known. Furthermore, little is known about dynamin-independent internalization mechanisms. One potential pathway for dynamin-independent internalization is through caveolae. These flask-shaped invaginations are much smaller than clathrin-coated pits and are characterized by high levels of cholesterol and glycosphingolipids (45) . The primary structural proteins of caveolae are termed caveolins. Recently, the bradykinin B2 receptor was shown to undergo redistribution into caveolae following activation by agonist (46, 47) . The M 2 mAChR also appears to be targeted to caveolae following activation (48), but it is not known if these receptor-caveolae complexes enter the cell or remain at the cell surface.
In summary, we have identified three regions within the M 2 mAChR that cooperate in agonist-dependent coupling to a dynamin-independent endocytic mechanism. Transfer of these M 2 -specific sequences into the M 1 mAChR was sufficient to confer the internalization-competent M 2 mAChR phenotype. Although the VTIL sequence has been previously implicated in the specificity of GPCR signaling (22, 23) , it is not sufficient for agonist-dependent endocytosis and requires additional information present in TM7 of the M 2 mAChR at Ala-438. Internalization of the M 2 mAChR is a complex process that can be mediated by both dynamin-independent and -dependent pathways. Identification of the structural requirements for entry into a dynamin-independent endocytic pathway will allow further analysis of this mechanism and the role it plays in the intracellular sorting of GPCRs.
